Form 4: Cencora CEO Robert Mauch Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Cencora's President and CEO, Robert P. Mauch, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 21, 2025, Robert P. Mauch, President & CEO of Cencora, Inc., executed a transaction involving the company's stock.
- Mauch exercised non-qualified stock options to acquire 3,225 shares of common stock at a price of $86.09 per share.
- Simultaneously, Mauch sold 4,969 shares of common stock at a price of $289.33 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 15, 2024.
- Following these transactions, Mauch directly owns 47,582 shares of Cencora common stock and 35,477 derivative securities (non-qualified stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions under a pre-existing trading plan. It doesn't inherently indicate positive or negative prospects for the company.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Insider transactions are routinely monitored and reported, providing transparency into executive sentiment and potential future company performance. The use of a 10b5-1 plan suggests a pre-arranged strategy to avoid accusations of trading on inside information.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across publicly traded companies, particularly in the pharmaceutical distribution industry.
- Companies like McKesson and Cardinal Health also have executives who utilize 10b5-1 trading plans.
- The specific details of these plans and the frequency of transactions vary based on individual circumstances and company policies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The use of a 10b5-1 plan aims to ensure fair and transparent trading practices, which benefits all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 11/13/2020 | First exercisable date for a portion of the non-qualified stock options. |
| 11/13/2021 | Second exercisable date for a portion of the non-qualified stock options. |
| 11/13/2022 | Third exercisable date for a portion of the non-qualified stock options. |
| 11/13/2023 | Fourth exercisable date for a portion of the non-qualified stock options. |
| 11/15/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 04/21/2025 | Date of the stock option exercise and stock sale. |
| 04/22/2025 | Date of the Form 4 filing. |
| 11/13/2026 | Expiration date of the non-qualified stock options. |
Keywords
Cencora, Robert Mauch, Stock Options, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Equity, COR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.